Joseph H. Friedman, MD* in his new book Making the Connection Between Brain and Behavior: Coping with Parkinson’s Disease, released on November 28, 2007

redline.jpg

Essays by Dr. Friedman:

Why Parkinson's Disease Patients Should Not Go to the Emergency Room

Hospitalization of a Parkinson Patient

redline.jpg

About the Author
Dr. Friedman is the co-author with Jeanne M. Hannah of Taking Charge: Good Medical Care for the Elderly and How to Get It, ISBN 13 978-0-97-798370-4, published in 2006 by Old Mission Press.

Dr. Joseph H. Friedman obtained his bachelor's degree at the University of Chicago in mathematics, master's degree in math from Washington University, MD from Columbia University College of Physicians and Surgeons, Neurology Residency at the Neurological Institute of New York, Columbia-Presbyterian Medical Center and then moved to Rhode Island in 1982.

Dr. Friedman is a Clinical Professor of Neurology in the Department of Clinical Neurosciences at Brown University Medical School. He is also the Director of NeuroHealth Parkinson's Disease and Movement Disorders Center in Warwick, Rhode Island. He is also the Editor in Chief of Medicine and Health, Rhode Island (the state medical journal, a joint publication of the Rhode Island Medical Society, Brown University, the Rhode Island Dept of Health and Rhode Island Quality Partners).

Dr. Friedman is also an elected member of the American Academy of Neurology Movement Disorders Section Executive Committee, and a fellow of the American Academy of Neurology Movement. In addition, Dr. Friedman is the clinical director of the American Parkinson Disease Association information and referral center in Rhode Island.

Dr. Friedman pursues clinical research related to movement disorders, primarily Parkinson's disease, but also Huntington's disease, drug induced movement disorders, disease, etc. He has been involved in studying behavioral aspects of Parkinson's disease as his main focus. He is also interested in drug induced movement disorders, particularly those induced by antipsychotic drugs. He has been evaluating the atypical antipsychotic drugs in the treatment of drug induced psychosis in PD since 1984 and is involved, as PI of one multi center trial and as consultant in another. He has also been trying to better understand fatigue in PD, an area that has been little explored. Dr. Friedman and his colleagues collaborate extensively, and are currently involved in a study of a cholinesterase inhibiting drug to improve cognitive function in non-demented PD patients. They are participating in multicenter NIH funded studies evaluating the role of genetics in PD, and will be involved in clinical trials funded by the NIH of neuroprotective agents in PD, and in Huntington's disease.